Term
|
Definition
o May cause hypomagnesemia. Monitor serum magnesium prior to and periodically during therapy. |
|
|
Term
|
Definition
o May cause false-positive results for urine protein; test with sulfosalicylic acid. |
|
|
Term
|
Definition
o May cause hypomagnesemia. Monitor serum magnesium prior to and periodically during therapy. |
|
|
Term
|
Definition
o Carbamazepine, phenytoin, and rifampin may ↓ levels. |
|
|
Term
|
Definition
o physical dependence, psychological dependence (high doses or prolonged therapy) |
|
|
Term
Polyethylene glycol (GoLytely) |
|
Definition
o allergic reactions (rare) |
|
|
Term
|
Definition
|
|
Term
Magnesium hydroxide (Milk of magnesia)/ Maalox |
|
Definition
o Monitor serum phosphate, potassium, and calcium levels periodically during chronic use. May cause ↑ serum calcium and ↓ serum phosphate concentrations. |
|
|
Term
|
Definition
o May cause decreased serum phosphate concentrations with excessive and prolonged use. When used to treat hyperphosphatemia in renal failure patients, monitor phosphate levels. |
|
|
Term
|
Definition
o Drops can be mixed with 30 mL of cool water, infant formula, or other liquid as directed. Shake well before using. |
|
|
Term
|
Definition
o protein-losing enteropathy, tetany (with chronic use) |
|
|
Term
|
Definition
· Lab values to monitor: May cause increased serum glucose and decreased serum potassium with prolonged use. |
|
|
Term
|
Definition
· Lab values to monitor: May cause elevated blood glucose levels with prolonged use of preparations containing sugar. |
|
|
Term
Diphenoxylate/atropine (Lomotil) |
|
Definition
o may cause increased serum amylase concentrations. |
|
|
Term
|
Definition
|
|
Term
|
Definition
o diarrhea, anal irritation, rectal seepage of mineral oil |
|
|